Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial
Anahita Salehi, Parsa Namaei, Fateme Taghavizanjani, Sayna Bagheri, Kamyar Moradi, Mohammad Reza Khodaie Ardakani, Shahin Akhondzadeh
Topics & Concepts
RisperidoneExtrapyramidal symptomsTolerabilityPositive and Negative Syndrome ScalePlaceboInternal medicineRandomized controlled trialMedicineScale for the Assessment of Negative SymptomsSchizophrenia (object-oriented programming)Rating scaleClinical trialAntipsychoticPsychiatryBrief Psychiatric Rating ScaleAdverse effectPsychologyPsychosisPathologyDevelopmental psychologyAlternative medicineSchizophrenia research and treatmentCannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes